Article
A stable hepatitis D virus-producing cell line for host target and drug discovery
26 Nov 2022
Abstract excerpt
Chronic hepatitis D is the most aggressive form of chronic viral hepatitis. It is caused by super-infection of hepatitis B virus (HBV)-infected hepatocytes with hepatitis D virus (HDV). While the recent conditional approval of bulevirtide for HDV treatment offers a new therapeutic modality in Europe, there is an unmet medical need to further improve therapy. A more detailed characterization of virus-host...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
